Thumbi Mwangi of Washington State University in the U.S. will work at the Kenya Medical Research Institute in Kenya to test whether treatment of parasitic helminth infections reduces the severity of the co-occurring parasitic diseases malaria and East Coast Fever (ECF) in humans and cattle respectively, which are more difficult to treat. In many developing countries, humans carry more than one parasitic disease, but if and how they interact to affect disease impact, for example by modifying the immune response, is not well understood. Mwangi will perform a controlled field trial in Western Kenya to test the effect of anthelmintic drugs on the incidence and severity of malaria and ECF, and will also analyze the presence of specific cytokines, which are immune signalling molecules, to help understand how pathogen interactions occur.
Grant ID
OPP1098873
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Challenge
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False